Review
Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era

https://doi.org/10.1016/j.amjmed.2020.06.005Get rights and content

Abstract

It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart failure, and thromboembolic complications that portend poor outcomes related to COVID-19.

We summarize recent information for hospitalists and internists on the front line of this pandemic regarding its cardiovascular impacts and management and the need for cardiovascular consultation.

Keywords

Cardiovascular consult
Cardiovascular disease
COVID-19
Multidisciplinary care
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Cited by (0)

Funding: None.

Conflicts of Interest: Authors do not have conflicts or funding specific to this manuscript.

Authorship: All authors had access to the data and a role in writing this manuscript.

View Abstract